Sanofi reveals new R&D strategy

15-12-2017

France-headquartered Sanofi presented key updates to its research and development (R&D) strategy yesterday, outlining three key shifts.


Sanofi, research and development, strategy, biologics, licensing, proprietary assets,

More on this story

Sanofi to buy Bioverativ for $11.6bn
23-01-2018

LSIPR